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Abstract
Background: Hypoxia inducible factor-1 (HIF-1) is a transcription factor that functions to
maintain cellular homeostasis in response to hypoxia. There is evidence that HIF-1 can also trigger
apoptosis, possibly when cellular responses are inadequate to meet energy demands under hypoxic
conditions.
Methods: Cardiac derived H9c2 and renal tubular epithelial HK-2 cells expressing either the wild
type oxygen regulated subunit of HIF-1 (pcDNA3-Hif-1α) or a dominant negative version that
lacked both DNA binding and transactivation domains (pcDNA3-DN-Hif-1α), were maintained in
culture and exposed to hypoxia. An RNA interference approach was also employed to selectively
knockdown expression of Hif-1α. Apoptosis was analyzed in both H9c2 and HK-2 cells by Hoechst
and TUNEL staining, caspase 3 activity assays and activation of pro-apoptotic Bcl2 family member
Bax.
Results: Overexpression of pcDNA3-DN-Hif-1α led to a significant reduction in hypoxia -induced
apoptosis (17 ± 2%, P < 0.01) in H9c2 cells compared to both control-transfected and wild type
Hif-1α transfected cells. Moreover, selective ablation of HIF-1α protein expression by RNA
interference in H9c2 cells led to 55% reduction of caspase 3 activity and 46% reduction in the
number of apoptotic cells as determined by Hoechst 33258 staining, after hypoxia. Finally,
upregulation of the pro-apoptotic protein, Bax, was found in H9c2 cells overexpressing full-length
pcDNA3-HA-HIF-1α exposed to hypoxia. In HK-2 cells overexpression of wild-type Hif-1α led to
a two-fold increase in Hif-1α levels during hypoxia. This resulted in a 3.4-fold increase in apoptotic
cells and a concomitant increase in caspase 3 activity during hypoxia when compared to vector
transfected control cells. HIF-1α also induced upregulation of Bax in HK-2 cells. In addition,
introduction of dominant negative Hif-1α constructs in both H9c2 and HK-2 -cells led to decreased
active Bax expression.
Conclusion: These data demonstrate that HIF-1α is an important component of the apoptotic
signaling machinery in the two cell types.
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Hypoxia-inducible factor -1 is a transcription complex
composed of an alpha (Hif-1α) and a beta (Hif-1β) subu-
nit [1]. While Hif-1β is constitutively expressed, Hif-1α
levels are highly regulated by cellular oxygen tension and
determine the cellular responses to variations in the oxy-
gen tension [2,3]. Whenever Hif-1α is induced in a cell in
response to low oxygen conditions it primarily triggers a
number of pro-survival events such as increased expres-
sion of vascular endothelial growth factor (VEGF) and
hence angiogenesis, increased expression of genes for var-
ious glycolytic enzymes as well as for the glucose trans-
porter 1 (GLUT1) thereby enhancing glycolysis, and
activation of the erythropoietin gene and hence erythro-
poiesis [4].
Over the past decade it has become clear that hypoxia
induces programmed cell death, or apoptosis, through a
mitochondrial dependent process [5,6] involving release
of cytochrome c, activation of caspase 9 and subsequent
cleavage and activation of downstream, effector caspases
[7,8]. Multiple factors are involved in this programmed
cell death pathway but because it largely determines the
cellular response to hypoxia, Hif-1 has been a candidate to
also regulate hypoxia-induced apoptosis. Despite its clear
role in cellular protection, there have been a number of
reports demonstrating that Hif-1 also contributes to pro-
grammed cell death during hypoxia [e.g., [9-13]]. Recent
reports have centered on the effects of Hif-1 on transacti-
vation of the BNIP3 gene in certain cells such as cardiac
myocytes [11,13,14]. The BNIP3 gene product induces
apoptosis by binding and inhibiting the antiapoptotic
proteins Bcl-2 and Bcl-xL [11,13,14]. However, BNIP3 is
not present in all cells, and Hif-1 clearly does not induce
apoptosis in many cell types. For example, Hif-1 prevents
hypoxia-induced apoptosis in pancreatic cancer cells [15-
19]. Thus, the role of Hif-1 in apoptosis remains some-
what controversial and appears to be cell type and context
specific.
Previously, we have found that enhanced glycolytic
metabolism and GLUT1 expression markedly attenuate
hypoxia induced apoptosis [20-22] and that enhanced
glycolytic metabolism and GLUT1 expression suppress
levels of Hif-1α in hypoxic cardiac myocytes [23].
Recently hyperglycemia has been demonstrated to inhibit
HIF-1α expression, inhibit hypoxia-induced decreased
proliferation of vascular smooth muscle cells and a con-
comitant decrease in hypoxia response element (HRE)
promoter transactivation [24]. We therefore hypothesized
that reduction of Hif-1α induced by GLUT1 and glucose
metabolism was mechanistically important in the preven-
tion of apoptosis and that Hif-1 plays a proapoptotic role
in our systems, especially in the absence of glucose trans-
port. To test this latter hypothesis we determined the
effect of Hif-1α expression in both a cardiac myocyte cell
line and a kidney epithelial cell line. The rationale for
using two different cell lines was to underscore the impor-
tance of Hif-1 in two distinct cell types which are clinically
relevant for apoptosis in cardiac (H9c2) and renal (HK-2)
ischemia. We found that Hif-1 enhances apoptosis and
that hypoxia-induced apoptosis can be markedly sup-
pressed by either a dominant negative Hif-1α construct or
shRNA induced knockdown of Hif-1α. Hif-1α expression
is also associated with enhanced Bax activation in these
systems thereby providing a mechanistic link between
hypoxic stress and apoptosis in these two cell types.
Methods
Cell culture
The embryonic rat heart derived H9c2 cells were cultured
in DMEM (Gibco) supplemented with 10% fetal bovine
serum (Gibco), antibiotics (50 U/ml penicillin and 50 μg/
ml streptomycin) at 37°C in an atmosphere of 95% air
and 5% CO2. The human kidney epithelial cell line HK-2
(ATCC #CRL-2190) was grown in keratinocyte serum-free
basal medium (Gibco) supplemented with bovine pitui-
tary extract (50 μg/ml), recombinant epidermal growth
factor (5 μg/ml), 50 U/ml of penicillin and 50 μg/ml
streptomycin.
Establishment of hypoxic culture condition
Both H9c2 and HK-2 cells were grown to the desired con-
fluence in a regular tissue culture incubator and then
transferred to an air tight Plexiglas hypoxic chamber in
glucose-free medium containing 2% Oxyrase (0.025% for
HK-2 cells) as described previously [20]. Establishment of
environmental hypoxic conditions (< 1%) were achieved
by continuously flushing the chamber with a water satu-
rated mixture of 5% CO2 and 95% N2. Maintenance of the
desired O2 concentration was constantly monitored dur-
ing incubation using a microprocessor-based oxygen sen-
sor.
Generation of Constructs
The original Hif-1α construct containing the full length
human Hif-1α cDNA, nt 1–3389 (pCEP4/Hif-1α T7) was
obtained from Dr. Greg Semenza (Johns Hopkins, Balti-
more, Maryland). The mammalian expression constructs
encoding the HA-tagged version of wild type Hif-1α
(pcDNA3-HA-Hif-1α) and the Flag-tagged form of human
dominant negative (DN) Hif-1α (pcDNA3-Flag-DN-Hif-
1α) were generated by sub-cloning, respectively, the full
length human Hif-1α cDNA or a truncated Hif-1α cDNA,
in which the sequence encoding the N-terminal DNA
binding domain (amino acids #1–17) and the entire C-
terminal transactivation domain (amino acids #401–826)
was deleted by PCR, into the EcoR1 and XbaI sites of the
pcDNA 3 mammalian expression vector tag series con-Page 2 of 11
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HindIII and the EcoRI site, as previously described [25].
Transfection and Immunoblot analysis
H9c2 cells and HK-2 cells were seeded in 60 mm plates.
When the cells reached 50–60% confluence, transfection
with 500 ng-1 μg of control vector (pEGFP) or one of the
wild type or dominant negative Hif-1α constructs was car-
ried out using Fugene (Roche Biochemicals) according to
the manufacturer's protocol. Transfection efficiencies
were monitored by counting EGFP positive cells. In H9c2
and HK-2 cells the average transfection efficiency of six
independent experiments (n = 6) was 22 ± 5% and 48 ±
7.6% respectively. Two days after transfection, H9c2 cells
were subjected to 6–24 h of hypoxia in regular DMEM,
deficient in glucose, but supplemented with 10% FCS. For
HK-2 cells, hypoxia of 16 h was performed in complete
keratinocyte basal serum-free medium as outlined above.
Whole cell lysates were prepared according to standard
protocol. Cells were extracted with lysis buffer (50 mmol/
L Tris-HCl, pH 7.5, 5 mmol/L EDTA, 150 mmol/L NaCl,
0.5% Triton X-100, 10 mmol/l NaF, 0.1% SDS, 250 μmol/
L sodium orthovandate, 1 mmol/L PMSF and Complete
Protease Inhibitor Cocktail [Roche Biochemicals]), and
incubated at 4°C for 30 min. The lysates were sonicated
and centrifuged at 14,000 g for 30 min. The supernatants
were collected and stored at -70°C or used immediately.
Protein concentrations were determined by the BCA
(Pierce Biochemicals) method. Protein (100 μg) was sep-
arated on 6% (for Hif-1α detection) or 10% (for Bax
detection) polyacrylamide-SDS gel and blotted onto
nitrocellulose membranes (Hybond ECL, Amersham,
Pharmacia). After blocking with TBS/5% skim milk, the
membranes were incubated overnight at 4°C with pri-
mary antibodies against Hif-1α (1:500 dilution, Novus
Biologicals, Littleton, CO), the active monomer of Bax
(Monoclonal antibody 6A7, 0.5 μg/ml concentration,
Alexis Biochemicals, San Diego, CA) or total Bax (1:1000
dilution, Santa Cruz Biotechnology, Santa Cruz, CA), fol-
lowed by secondary antibodies conjugated with horserad-
ish peroxidase (1:10,000) (Pierce, Rockford, IL) for 1 h at
room temperature. Signals were detected with ECL.
shRNA treatment of cells
Multiple short hairpin (sh) RNA oligonucleotides to
human HIF-1α sequence were synthesized using an algo-
rithm for rational siRNA design [26]. The top and bottom
cDNA oligomers with a 4 nt loop sequence were annealed
to generate a double stranded oligo with 4-nucleotide
overhangs which was then used for directional cloning
into the BLOCK-iT™ U6 RNAi Entry vector kit (Invitrogen
Life Technologies). After completion of cloning the U6
entry vector with the inserted RNAi cassette was tran-
siently transfected into cells using Fugene (Roche Bio-
chemicals). shRNA oligos which generated optimal
silencing of Hif-1α had the following complementary
strand sequences : 5'-AGAGGUGGAUAUGUGUG-
GGdTdT-3' and 5'-CCAACACAUAUCCACCUCUdTdT-3'.
Apoptosis analysis
Assessment of cellular apoptotic morphologies after trans-
fection and hypoxia was accomplished by plating the
H9c2 and HK-2 cells in 2 well Falcon glass culture slides
(Becton Dickinson Labware, Franklin Lakes, NJ). pEGFP
was co-transfected with the other constructs to aid in the
identification of transfected cells for counting purposes.
The cells were rinsed in PBS, pH 7.4, and fixed for 30 min
in 4% paraformaldehyde in PBS at room temperature, and
rinsed again in PBS. The cells were then permeabilized in
0.1% Triton X-100 in 0.1% sodium citrate. The cells were
rinsed in PBS and then stained directly with anti-HA-fluo-
rescein or anti-Flag-fluorescein monoclonal antibodies
(Roche Biochemicals). After rinsing in PBS the cells were
also stained with the karyophillic dye Hoechst 33258 (5
μg/ml) for 10 min at room temperature. After a final rinse
in PBS the cells were mounted in moiwol (Polysciences,
Inc., Warrington, PA), an antifade agent, and visualized
under fluorescent light (for detection of EGFP, HA and
Flag epitopes respectively) and switched to ultraviolet
light (for visualization of Hoechst 33258) with a Leitz
Orthoplan microscope. The percentage of EFGP/HA/Flag
positive cells displaying chromatin condensation and
nuclear fragmentation was determined.
TUNEL staining
Further characterization of apoptosis in HK-2 cells was
performed using a commercially available in situ cell
death detection kit to find DNA strand breaks using the
terminal deoxynucleotidyl transferase-mediated dUTP
nick end labeling (TUNEL) reagent according to the man-
ufacturer's protocol (Boehringer Mannheim). The
number of TUNEL-positive cells was counted in five dif-
ferent fields by an observer blinded to cell treatment or
transfection status.
Caspase 3 activity assay
Caspase 3 activity was assessed via a colorimetric assay uti-
lizing specific substrates (Calbiochem). After treatment,
the cells were washed once with ice-cold PBS and col-
lected by trypsinization followed by centrifugation. The
cellular pellet was resuspended in cell lysis buffer and
incubated on ice for 10 min. Lysates were centrifuged for
5 min at 13,000 rpm, and the supernatants were assayed
for caspase 3 activity in assay buffer (50 mM HEPES, pH
7.4, 100 mM NaCl, 0.1% CHAPS, 10 mM dithiothreitol,
0.1 mM EDTA, 10% glycerol). After addition of DEVD-
specific caspase substrate (2 mM) samples were incubated
for 60 min at 37°C and read at 405 nm in an EL-312 Bio-
Kinetics microplate reader (Bio-Tek Instruments).Page 3 of 11
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H9c2 and HK-2 cells were transfected with both pEGFP
and pcDNA3-HA-Hif-1α as described above. After 24 h of
transfection the cells were trypsinized and suspended in
Dulbecco's PBS at a concentration of at least 1 × 106 cells/
ml. The cells were analyzed and sorted in a Flow cytome-
ter (FACS Vantage SE, Becton Dickinson) to obtain only
EGFP positive cells based on laser excitation wavelengths
of 488 nm and emission wavelength of 525 nm. The
sorted cells were allowed to acclimatize for a few hours in
a tissue culture incubator and then subjected to hypoxia of
6 h, followed by immunoblotting to examine active Bax as
well as total Bax in total cellular lysates as described
above.
Statistics
Data were expressed as mean ± S.E. unless otherwise indi-
cated in the figure legends. Analysis of variance was fol-
lowed by Bonferroni's post-hoc analysis, and differences
were regarded as significant at a p value < 0.05.
Results
Overexpression of a dominant negative Hif1-1α reduces 
hypoxia-induced apoptosis in H9c2 cells
H9c2 cells were transfected with either control vectors or
wild-type or dominant negative Hif-1α constructs. Under
normoxic conditions there was no increase in the number
of apoptotic cells or detectable Hif-1α levels after transfec-
tion with either the wild type or truncated Hif-1α con-
structs. These findings were consistent with proteasomal
degradation of Hif-1α in the presence of O2, as the oxygen
degradation domain is intact in both the wild type and
dominant negative constructs. (Fig. 1A). However overex-
pression of the dominant negative Hif-1α that lacks both
DNA binding and transactivation domains significantly
reduced the number of apoptotic cells during hypoxia
(17+2% in dominant negative cells, 44.7+4.4% apoptotic
cells in wild type Hif-1α transfected cells, and 38.5+3.8%
in EGFP transfected cells) (Fig. 1B). Thus, in H9c2 cells
Hif-1 seems to be partly responsible for the observed
hypoxia-induced apoptosis in the absence of glucose.
Knock down of hypoxia-induced expression of Hif-1α with 
RNA interference (RNAi) reduces hypoxia induced 
apoptosis in H9c2 cells
To confirm the specificity of the cellular apoptosis
response to Hif-1 seen in H9c2 cells, an alternative
approach using shRNAiHIF-1α was employed. When trans-
fected into cells, siRNA-Hif-1α targets HIF-1α mRNA for
degradation, thus blocking HIF-1 activity [26]. H9c2 cells
were treated with shRNAiHif-1α for 24 h followed by 24 h
of hypoxia and finally immunoblotting to assess Hif-1α
protein expression. Under hypoxic conditions Hif-1α pro-
tein was suppressed in H9c2 cells treated with shRNAiHif-
1α (200 nM) when compared to cells transfected with
shRNA targeted to a scrambled mRNA sequence (negative
control) (Fig. 2). Densitometry analysis revealed a 76 ±
8.5% decrease in Hif-1α levels in cells transfected with
A) Hif-1 α protein expression in whole cell lysates of H9c2 cells transfected with either pEGFP or pcDNA3-HA-HIF-1α and subjected to normo ia or hypoxia for 12 hFigure 1
A) Hif-1 α protein expression in whole cell lysates of H9c2 cells transfected with either pEGFP or pcDNA3-HA-HIF-1α and 
subjected to normoxia or hypoxia for 12 h. Immunoblotting with antibodies against HIF-1β, the nuclear dimerization partner of 
HIF-1α was used to monitor equal protein loading. B) HIF-1α mediates hypoxia-induced apoptosis in H9c2 cells transfected 
with pEGFP or pcDNA3-HA-HIF-1α expressing the wild type HIF-1α or pcDNA3-Flag-DN-HIF-1α expressing the dominant 
negative version as described in methods. Cells were exposed to normoxia or hypoxia for 12 h in glucose-deficient medium. 
The number of cells displaying condensed and fragmented nuclei was counted only in cells positive for each respective epitope 
tag or EGFP. The results are representative of five independent experiments. *P < 0.01 vs. hypoxia in pEGFP and pcDNA3-HA-
Hif-1α.Page 4 of 11
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targeted to a scrambled sequence (P < 0.001, n = 3). The
selective reduction of Hif-1α levels resulted in a decrease
in apoptosis as documented by a reduction of caspase 3
activity by 55% compared to negative controls and cells
transfected with the empty U6RNAi vector alone (P <
0.01) (Fig 3A). Similarly, the number of cells that were
morphologically apoptotic, based on staining with the
karyophillic dye Hoechst 33258, were decreased 46% by
shRNAiHif-1α treatment (p < 0.05). (Fig. 3B). These find-
ings confirmed that a decrease in apoptosis was a specific
result of reduction of active Hif-1α.
Hif-1α promotes Bax activation in H9c2 cells
To gain insight into the mechanisms underlying apoptosis
by Hif-1α in H9c2 cells, the induction of the proapoptotic
protein Bax was investigated. The 6A7 antibody detects an
epitope at the N terminus of Bax that is occluded in the
inactive state and is exposed upon Bax activation [27].
H9c2 cells, transfected with pEGFP, DN and wild-type
Hif-1α vectors, were selected as described in Materials and
Methods. Whole cell lysates of H9c2 cells expressing EGFP
and wild type Hif-1α demonstrated a strong activation of
Bax, while lysates of cells expressing EGFP alone displayed
little Bax activation (Fig. 4). Interestingly, H9c2 cells
transfected with DN Hif-1α displayed reduced Bax expres-
sion thereby suggesting that Hif-1α was responsible for
Bax activation. Although we did not observe any signifi-
cant increase in apoptosis under similar transfection con-
ditions (Fig. 1) these results suggest that Hif-1α may
promote Bax activation during hypoxia. Under normoxic
conditions active Bax was not detected in cells transfected
with pEGFP alone or pEGFP plus Hif-1α (Fig. 4).
Hif-1α overexpression induces apoptosis in human kidney 
epithelial HK-2 cells
We also extended our studies on Hif-1α and apoptosis to
the kidney epithelial cell line, HK-2. Transfection of HK-2
cells with a native Hif-1α construct resulted in an almost
two fold increase in total Hif-1α levels in the cells trans-
fected with wild-type Hif-1α (Fig. 5A). Using a combina-
tion of three approaches to document apoptosis in these
cells, we found that transfection with wild type Hif-1α fol-
lowed by hypoxia of 16 h resulted in substantial apoptosis
whereas, under these conditions at least, there was no sig-
nificant increase in apoptosis in hypoxic vector-control
transfected cells (Fig. 5 B–D). These findings are some-
what different than those in H9c2 cardiac cells which
demonstrated substantial hypoxia-induced apoptosis that
was not augmented by Hif-1α overexpression, but which
was ameliorated when Hif-1α was reduced or inhibited.
Increased total Hif-1α and active Bax in Hif-1α 
transfected HK-2 cells
We further explored whether Hif-1α overexpression was
also associated with increased Bax activation in HK-2
cells. HK-2 cells were transfected with vector alone
(pEGFP) with wild type Hif-1α and pEGFP or with DN
Hif-1 and EGFP as described above. EGFP positive cells
were allowed to acclimatize in the tissue culture incubator
and subsequently subjected to 16 h hypoxia or normoxia.
Immunoblotting of the same lysates demonstrated an
upregulation of active Bax in cells transfected with
pcDNA3-HA-Hif-1α compared to cells transfected with
DN-Hif-α (Fig. 6), suggesting that Hif-1 enhanced Bax
activation during hypoxia and DN Hif-1α was effective in
reducing both Bax expression and the resultant apoptosis.
Discussion
Hif-1 is critical for the cellular response to hypoxia as it
serves to transactivate a number of genes responsible for
cellular survival [4]. Conversely, Hif-1 can also stimulate
the mitochondrial apoptotic pathway and cell death dur-
ing hypoxia, [e.g., [9-11,13]]. However, the role of Hif-1
in hypoxia-induced apoptosis remains controversial, and
several reports have found that Hif-1 actually protects
some cell types from apoptosis, presumably in a cell-type
and context specific manner [e.g., [15-19]]. We previously
found that glucose uptake and metabolism or enhanced
expression of the facilitative glucose transporter, GLUT1,
protected cardiac myocytes and other cell types from
hypoxia-induced apoptosis via reduced mitochondrial 
Effect of shRNA treatment on HIF-1α protein expression in H9c2 cellsFigure 2
Effect of shRNA treatment on HIF-1α protein expression in 
H9c2 cells. H9c2 cells were transfected with shRNAiHIF-1α 
(200 nM) or an shRNAi targeted to a scrambled mRNA 
sequence (Scr siRNA, nonspecific control), and 24 h later 
were subjected to hypoxia for an additional 24 h and subse-
quently whole cell lysates were isolated for Western blot 
analysis for HIF-1α protein expression. The data shown is 
from two independent experiments. As a loading control the 
lysates were also probed with an antibody against Hif-1β, the 
dimerization partner of Hif-1α.Page 5 of 11
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Flow cytometry analysis followed by Bax protein expression. H9c2 cells were transfected with pEGFP, pEGFP and pcDNA3-
HA- HIF-1α or pcDNA3-Flag-DN-HIF-1α and were sorted in a flow cytometer. The EGFP positive sorted cells were subjected 
to hypoxia for 6 h. Total Bax expression in the same lysates was used to monitor protein loading. N = Normoxia; H = Hypoxia. 
The data are representative of 3 separate experiments and only 2 experiments using dominant negative Hif-1α (right panel).
Downregulation of HIF-1α by shRNAi treatment reduces hypoxia-induced apoptosis in H9c2 cellsFigure 3
Downregulation of HIF-1α by shRNAi treatment reduces hypoxia-induced apoptosis in H9c2 cells. After co-transfection with shRNAHIF-1α 
or an shRNAi targeted to an unrelated mRNA sequence (Scr shRNA, nonspecific control) or with the U6RNAi empty vector and pEGFP 
the H9c2 cells were cultured under normoxic or hypoxic conditions for an additional 24 h. (A) After transfection with respective shRNAi 
constructs and exposure to normoxic or hypoxic conditions the cells were analysed for caspase 3 activity. Results are mean ± SEM of 4 
separate experiments. (B) Cells were stained with Hoechst 33258 and visualized under ultraviolet light. The data represent the mean ± 
SEM of triplicate wells of three independent experiments. *P < 0.05 vs. hypoxia in U6 RNAi vector and Scr shRNAi.Page 6 of 11
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22]. In addition, we found that enhanced glucose uptake
and metabolism or increased GLUT1 expression resulted
in reduced Hif-1α levels due to enhanced Hif-1 α proteo-
somal degradation despite persistent hypoxia in these
same cardiac myocytes and heart-derived H9c2 cells [23].
A similar effect of hyperglycemia on reduction of Hif-1α
levels and apoptosis has been demonstrated in vascular
smooth muscle cells [24]. In a rat model of cerebral
ischemia both mRNA and protein expression of Hif-1α
and procaspase 3 was also shown to be increased after 12-
and 24-hours of ischemic insult and increase in specific
Hif-1 binding to the caspase 3 gene promoter [28]. There-
fore, we hypothesized that Hif-1 promoted mitochondrial
cell death pathway in H9c2 cells and that glucose-induced
reduction in Hif-1α levels contributed to the anti-apop-
totic effects of glucose uptake and metabolism.
The present report demonstrates that Hif-1α potentiates
apoptosis under hypoxic conditions in both rat H9c2 cells
Effect of HIF-1α overexpression on apoptosis in HK-2 subjected to 16 h of hypoxiaFigure 5
Effect of HIF-1α overexpression on apoptosis in HK-2 subjected to 16 h of hypoxia. (A) HIF-1α protein expression in HK-2 
cells transfected with either the empty vector or pcDNA3-HA-Hif1α and subjected to hypoxia or normoxia. Immunoblotting 
of the same lysates with Hif-1β to monitor protein loading is also shown. (B) Morphological analysis of apoptosis with Hoechst 
33258. *P < 0.05 vs hypoxia in pcDNA3. pEGFP was co-transfected alongwith the vector and HIF-1 alpha construct to aid in 
the identification of apoptotic nuclei in EGFP transfected cells. (C) Apoptotic cells as determined by TUNEL staining. *P < 0.001 
vs hypoxia after transfection with pcDNA3. Data shown is mean ± SEM of six separate experiments and (D) Caspase 3 activity 
(O.D. units 405 nm).*P < 0.001 vs. hypoxia with the empty vector pcDNA3. Data in panels B, C and D are means ± SEM of 
triplicate wells of six separate experiments.Page 7 of 11
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a dominant negative Hif-1α that lacked DNA binding
domain and the C-terminal transactivation domain as
well as shRNA targeted to Hif-1α decreased hypoxia-
induced apoptosis in H9c2 cells. Conversely, overexpres-
sion of wild type Hif-1α increased apoptosis in HK-2 cells,
whereas it had little effect in H9c2 cells, suggesting that
levels of Hif-1α in these cells during hypoxia were already
sufficient to maximally trigger apoptosis. These differ-
ences may reflect the relative levels of Hif-1α in the two
cell lines and also the threshold of Hif-1α overexpression
needed to trigger a significant apoptotic response. Thus, in
HK-2 cells with the existing endogenous levels of Hif-1α,
hypoxia could have resulted in relatively small increases
in caspase activity and apoptosis, but augmenting Hif-1 α
levels boosted those apoptotic features. On the other
hand, in H9c2 cells overexpression of Hif-1α had little
effects on apoptosis, but reduction of Hif-1α inhibited
apoptosis.
These observations are consistent with other studies
showing that Hif-1 promotes apoptosis in cardiac myo-
cytes and other cells by induction of the cell death factors
BNIP3 and NIX [11,13,29,30] or by stabilizing the tumor
suppressor protein p53 [31]. As noted above, however,
several studies have reported that Hif-1α is a prosurvival
factor and can protect cells from hypoxia-induced apopto-
sis [15,17-19]. Most of these latter studies have been per-
formed in tumor or tumor derived cells in which
adaptation to the hypoxic microenvironment leads to the
selection of certain malignant tumor phenotypes, which
may select Hif-1 as a survival factor.
In cardiac myocytes and kidney epithelial cells which
under normal circumstances are not normally exposed to
a hypoxic microenvironment, Hif-1 may serve dual roles
as a survival and death factor depending upon the severity
and duration of insult or injury. For example, a recent
study in which primary cardiac myocyte cultures were
exposed to metabolic inhibition with cyanide and 2-deox-
yglucose documented survival benefits of inhibiting the
family of the O2-dependent prolyl hydroxylase (PHD)
enzymes responsible for targeting Hif-1α for proteosomal
degradation [32]. These inhibitors stabilize Hif-1α levels.
This report suggested that under certain circumstances,
Hif-1 can be anti-apoptotic in cardiac myocytes. However,
there may have been some nonspecific effects in this study
since the two inhibitors used in this report were used at
concentrations somewhat higher than in most other
reports (500 μM) and would have affected levels of other
proteins. Nonetheless, other recent studies have corrobo-
rated the protective effects of HIF-1-dependent pathways
in cardiac myocytes by overexpressing constitutively sta-
ble hybrid forms of HIF-1α or with small interfering RNA
(siRNA) directed against HIF-1α-prolyl-4–hydroxylase-2
gene, thus stabilizing HIF-1α [33,34]. Why our results dif-
fer from these previous reports is unclear, and could be
due to the use of somewhat different cell systems and con-
HIF-1α promotes Bax activation in HK-2 cellsFigure 6
HIF-1α promotes Bax activation in HK-2 cells. Cells were subjected to normoxia or hypoxia of 16 h after sorting in a flow 
cytometer. Active and Total Bax protein expression of the whole cell lysates of EGFP positive cells is shown of cells transfected 
with either pEGFP or pEGFP and pcDNA3-HA-Hif-1α or pcDNA3-DN-Hif-1α. N = Normoxia; H = Hypoxia. Data shown is 
representative of two separate experiments.Page 8 of 11
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combined both true hypoxia with glucose withdrawal.
Since we and others have clearly shown that glucose
uptake and metabolism helps protect cells from various
extracellular stresses including hypoxia and growth factor
withdrawal-induced apoptosis [20-22,35-37], the absence
of this protective response will allow greater Hif-1α activ-
ity [23] and possibly potentiate its pro-apoptotic activity.
Hypoxia has also been shown to activate the Unfolded
Protein Response (UPR), an essentially adaptive response
that occurs in the endoplasmic reticulum (ER) in response
to stresses that reduce or alter protein folding [38,39].
Though recent reports demonstrate that hypoxia activates
the UPR in cardiac myocytes [40] which may potentially
protect the myocardium during hypoxic stress, the fact
that in the event of an unresolved ER stress the UPR can
also activate the apoptotic cell death program [41,42] also
needs to be addressed.
Finally, our studies suggest, but do not prove, that Hif-1α
promotes apoptosis by activating the proapoptotic Bcl-2
family protein Bax. Previous reports have suggested that
Hif-1 is necessary for hypoxia-induced Bax expression
[43]. However, other reports have not substantiated this
relationship [16]. Consistent with our observations, a
recent report also demonstrates hypoxia-mediated apop-
tosis in temperature sensitive rat proximal tubular cells
through a mechanism independent of Bax upregulation at
least at the permissive temperature [44]. Whether Hif-1
directly activates Bax gene expression or induces Bax
expression through some intermediate factor or factors is
not clear and needs further investigation. In both H9c2
and HK-2 cells Hif-1 expression leads to upregulation of
active Bax and introduction of dominant negative con-
structs of Hif-1α leads to reduced Bax expression. Whether
Bax directly contributed to increased apoptosis in HK-2
and H9c2 cells still needs to be addressed. One obvious
candidate which could be involved in Bax induction is the
tumor suppressor protein p53. Numerous studies have
documented that Hif-1 stabilizes p53 [31,45] and that
p53 can induce Bax translocation and thus engage the
mitochondrial cell death pathway [46,47]. Simultane-
ously hypoxia leads to increased mitochondrial reactive
oxygen species (ROS) generation [48] and previous
reports have convincingly demonstrated that these mito-
chondrial ROS are both sufficient and necessary to acti-
vate HIF [49]. Activation of HIF-1a by a redox-senstive
pathway has also been shown to promote mitochondrial
cell death pathway by upregulating BNIP3 [50] thereby
providing a complex regulatory network where HIF-1α
induction either upstream or downstream of the mito-
chondria finally leads to increased expression of mito-
chondrial death factors (Bax, BNIP3 etc) and resultant
apoptosis.
Conclusion
Hif-1 plays a master regulatory role in the cellular
response to hypoxia. In certain circumstances and in cer-
tain cell types, Hif-1 promotes apoptosis in the presence
of hypoxia, especially when other cellular energy sub-
strates are lacking.
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